The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison

被引:7
作者
Cowell, Ian G. [1 ]
Ling, Elise M. [1 ]
Swan, Rebecca L. [1 ]
Brooks, Matilda L. W. [1 ]
Austin, Caroline A. [1 ]
机构
[1] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
基金
英国生物技术与生命科学研究理事会;
关键词
SMALL-MOLECULE INHIBITOR; CLEAVABLE COMPLEXES; IN-VIVO; BETA; ALPHA; BINDING; CONJUGATION; ACTIVATION; LONGEVITY; LEUKEMIA;
D O I
10.1124/mol.119.117390
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2,6-Diaminopyridine-3,5-bis(thiocyanate) (PR-619) is a broad-spectrum deubiquitinating enzyme (DUB) inhibitor that has been employed in cell-based studies as a tool to investigate the role of ubiquitination in various cellular processes. Here, we demonstrate that in addition to its action as a DUB inhibitor, PR-619 is a potent DNA topoisomerase II (TOP2) poison, inducing both DNA topoisomerase IIa (TOP2A) and DNA topoisomerase IIb (TOP2B) covalent DNA complexes with similar efficiency to the archetypal TOP2 poison etoposide. However, in contrast to etoposide, which induces TOP2-DNA complexes with a pan-nuclear distribution, PR-619 treatment results in nucleolar concentration of TOP2A and TOP2B. Notably, neither the induction of TOP2-DNA covalent complexes nor their nucleolar concentration are due to TOP2 hyperubiquitination since both occur even under conditions of depleted ubiquitin. Like etoposide, since PR-619 affected TOP2 enzyme activity in in vitro enzyme assays as well as in live cells, we conclude that PR-619 interacts directly with TOP2A and TOP2B. The concentration at which PR-619 exhibits robust cellular DUB inhibitor activity (5-20 mM) is similar to the lowest concentration at which TOP2 poison activity was detected (above 20 mM), which suggests that caution should be exercised when employing this DUB inhibitor in cell-based studies.
引用
收藏
页码:562 / 572
页数:11
相关论文
共 24 条
  • [21] Potent Anti-Ovarian Cancer with Inhibitor Activities on Both Topoisomerase II and V600EBRAF of Synthesized Substituted Estrone Candidates
    El-Naggar, Mohamed
    Amr, Abd El-Galil E.
    Fayed, Ahmed A.
    Elsayed, Elsayed A.
    Al-Omar, Mohamed A.
    Abdalla, Mohamed M.
    MOLECULES, 2019, 24 (11):
  • [22] Anticancer Activity of Indeno[1,2-b]-Pyridinol Derivative as a New DNA Minor Groove Binding Catalytic Inhibitor of Topoisomerase IIα
    Jeon, Kyung-Hwa
    Shrestha, Aarajana
    Jang, Hae Jin
    Kim, Jeong-Ahn
    Sheen, Naeun
    Seo, Minjung
    Lee, Eung-Seok
    Kwon, Youngjoo
    BIOMOLECULES & THERAPEUTICS, 2021, 29 (05) : 562 - 570
  • [23] Exploration of anti-leukemic effect of soft coral-derived 13-acetoxysarcocrassolide: Induction of apoptosis via oxidative stress as a potent inhibitor of heat shock protein 90 and topoisomerase II
    Chin, Hsien-Kuo
    Lu, Mei-Chin
    Hsu, Kai-Cheng
    El-Shazly, Mohamed
    Tsai, Tsen-Ni
    Lin, Tzu-Yung
    Shih, Shou-Ping
    Lin, Tony Eight
    Wen, Zhi-Hong
    Yang, Yu-Chen S. H.
    Liu, Yi-Chang
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (07) : 718 - 731
  • [24] DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody-Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
    Yamato, Michiko
    Hasegawa, Jun
    Maejima, Takanori
    Hattori, Chiharu
    Kumagai, Kazuyoshi
    Watanabe, Akiko
    Nishiya, Yumi
    Shibutani, Tomoko
    Aida, Tetsuo
    Hayakawa, Ichiro
    Nakada, Takashi
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (04) : 635 - 646